Argentina vs Belgium: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Argentina
- Belgium
How they compare
Argentina currently reports 23.5% against 23.5% in Belgium, a difference of 0.0%.
The two have swapped places 1 time across 9 shared years of data; in 2000 it was Argentina ahead.
Argentina ranks 57th and Belgium ranks 57th of 166 countries.
Argentina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Belgium | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.3% | 28.6% | 2.7% | Argentina |
| 2010s | 27.7% | 26.4% | 1.3% | Argentina |
| 2020s | 24.1% | 23.9% | 0.2% | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Argentina or Belgium?
- Argentina, at 23.5% against 23.5% in Belgium as of 2024.
- What is the difference in prevalence of current tobacco use between Argentina and Belgium?
- 0.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Belgium?
- 9 years are reported by both, from 2000 to 2024.
- How do Argentina and Belgium rank globally for prevalence of current tobacco use?
- Argentina ranks 57th and Belgium ranks 57th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.